Watch CSTL. Know when insiders buy.
One email the day a filing lands. Free.
Work order
24
FLAG · insiders 25, shorts 23
Insiders, 90 days
−$2M
net selling · 0 buys, 17 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1BP/E —DIV YIELD —FCF YIELD -0.05%REV TTM $357.3M +3.2%NET INCOME −$19.4MNET CASH $52M52W 18.15 – 43.04SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $103.5M | +20.1% | 77.1% | −$3.1M | −$2.1M | −145.5% | -0.07 | $15.2M | $8.7M | $6.6M | Jul 30 |
| Q1 2026 · Mar 31 | $83.7M | −4.9% | 75.5% | −$18.4M | −$14.5M | — | -0.49 | −$22.1M | $12.5M | −$34.6M | Jul 30 |
| Q4 2025 · Dec 31derived | $87M | +0.8% | 79.0% | −$3.8M | −$2.3M | −124.3% | -0.07 | $26.9M | $7.2M | $19.7M | Feb 26 |
| Q3 2025 · Sep 30 | $83M | −3.2% | 77.5% | −$6.8M | −$501K | −122.1% | -0.02 | $22.6M | $14.8M | $7.8M | Nov 3 |
| Q2 2025 · Jun 30 | $86.2M | −0.9% | 79.5% | −$4.3M | $4.5M | −49.3% | 0.15 | $20.8M | $9.3M | $11.6M | Jul 30 |
| Q1 2025 · Mar 31 | $88M | +20.6% | 81.4% | −$27.9M | −$25.8M | — | -0.90 | −$6M | $4.7M | −$10.8M | Jul 30 |
| Q4 2024 · Dec 31derived | $86.3M | +30.5% | 81.3% | $4M | $9.6M | — | 0.32 | $24.4M | $7.6M | $16.8M | Feb 26 |
| Q3 2024 · Sep 30 | $85.8M | +39.5% | 81.8% | $5.1M | $2.3M | — | 0.08 | $23.3M | $6.4M | $17M | Nov 3 |
| Q2 2024 · Jun 30 | $87M | — | 83.3% | $5M | $8.9M | — | 0.31 | $24M | $5.2M | $18.8M | Nov 3 |
| Q1 2024 · Mar 31 | $73M | — | 81.0% | −$5.5M | −$2.5M | — | -0.09 | −$6.8M | $9.2M | −$16M | Nov 3 |
| Q4 2023 · Dec 31derived | $66.1M | — | 81.2% | −$5.7M | −$2.6M | — | -0.09 | $18.6M | $3.8M | $14.8M | Feb 26 |
| Q3 2023 · Sep 30 | $61.5M | — | 81.6% | −$9.6M | −$6.9M | — | -0.26 | $5M | $2.5M | $2.6M | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $344.2M | 79.4% | −$42.8M | −$24.2M | -7.0% | -0.83 | $64.3M | $36M | $28.3M | — | — |
| FY2024 · to Dec 31 | $332.1M | 81.9% | $8.7M | $18.2M | 5.5% | 0.62 | $64.9M | $28.3M | $36.5M | — | — |
| FY2023 · to Dec 31 | $219.8M | 79.5% | −$68M | −$57.5M | -26.1% | -2.14 | −$5.6M | $13.6M | −$19.2M | — | — |
| FY2022 · to Dec 31 | $137M | 76.6% | −$72.9M | −$67.1M | -49.0% | -2.58 | −$41.7M | $5.6M | −$47.3M | — | — |
| FY2021 · to Dec 31 | $94.1M | 83.2% | −$40.1M | −$31.3M | -33.3% | -1.24 | −$19M | $3.5M | −$22.5M | — | — |
| FY2020 · to Dec 31 | $62.6M | 84.5% | −$6.5M | −$10.3M | -16.4% | -0.54 | $9.9M | $4.8M | $5.1M | — | — |
Every number comes from CASTLE BIOSCIENCES INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.